Page 4 - Marie Campinell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cue Biopharma Announces Upcoming Scientific Presentations

BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of.

United statesSan diegoJennifer eva selfridgeChristine chungMaya romanchukMarie campinellUniversity hospitals cleveland medical centerCorporate communicationsSociety for immunotherapy of cancerH lee moffitt cancer centerLifesci communicationsSecurities exchangeDrug administrationCue biopharma incAnniversary annual meetingMoffitt cancer center

Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®

Completed enrollment of patient expansion cohort of 20 patients at the RP2D of 4 mg/kg in combination with KEYTRUDA® (pembrolizumab) in first line.

United statesMaya romanchuckMatteo levisettiMarie campinellDaniel passeriCorporate communicationsSecurities exchangeCue biopharma incSociety for immunotherapy of cancerDrug administrationLifesci communicationsNeck cancerAnnual meetingFast track designationCue biopharmaWilm tumor

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesMarie campinellMaya romanchuckDaniel passeriCorporate communicationsOno pharmaceutical co ltdCue biopharma incSecurities exchangeAmerican society of clinical oncologyLifesci communicationsSociety for immunotherapy of cancerDrug administrationCue biopharmaClinical oncologyAnnual meetingWilm tumor

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel passeriMaya romanchuckMarie campinellSecurities exchangeDrug administrationCorporate communicationsAmerican society of clinical oncologySociety for immunotherapy of cancerLifesci communicationsOno pharmaceutical co ltdCue biopharma incClinical oncologyAnnual meetingWilm tumorConsolidated statement

Cue Biopharma to Present at the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting

BOSTON, June 14, 2023 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T. | June 14, 2023

United statesSaint louis universityMarie campinellSteven quayleDrug administrationCorporate communicationsSecurities exchangeCue biopharma incOno pharmaceutical co ltdFederation of clinical immunology societiesResearch biology translational medicineSelective targetingClinical immunology societiesResearch biologyTranslational medicineWilm tumor